• ClinGen and Lessons for the Precision Medicine Initiative

    Jun 10, 2015, 10:00 AM by Michael Croft
    Bio-IT World | Heidi Rehm has been involved in ClinGen since its inception and recently published a report on the project in the New England Journal of Medicine. Rehm’s experience with ClinGen will make hers an important voice as the infrastructure needs for a Precision Medicine Initiative are better defined.
    Full story
  • DIGITAL SCIENCE ANNOUNCES NEW MANAGING DIRECTOR

    Jun 9, 2015, 00:00 AM by Michael Croft
    BOSTON, MA, UNITED STATES - Jun 9, 2015 - London, UK & Boston, USA. June 9th 2015:  Digital Science announced today the appointment of Daniel Hook, currently Director of Research Metrics at Digital Science, as its new Managing Director
    Full story
  • BGI's Industrial Scale Sequencer Challenges Illumina's HiSeq Line

    Jun 8, 2015, 17:00 PM by Michael Croft
    Bio-IT World | BGI, the Shenzhen-based global genomics corporation, has revealed its first DNA sequencing instrument for worldwide markets, Revolocity: an ultra-high-throughput, fully automated system based on technology developed by BGI's subsidiary Complete Genomics.
    Full story
  • Kickstarter Launched for Social Reader

    Jun 8, 2015, 16:00 PM by Michael Croft
    Bio-IT World | David Mittelman and his colleagues at N of Everyone today launch a Kickstarter campaign to fund Reader, a mobile and social reading platform to promote conversation and collaboration within science. 
    Full story
  • A New Regenerative Drug Molecule For Pancreas Was Introduced

    Jun 8, 2015, 00:00 AM by Michael Croft
    NEW YORK, NY - Jun 8, 2015 - BOC Sciences-recently a new synthetic molecule was introduced by an authoritative research center in America
    Full story
  • The Human Virome's Permanent Mark

    Jun 5, 2015, 13:50 PM by Michael Croft
    Bio-IT World | The human body is host to an astonishing array of viruses, but efforts to study this secretive population have hit technological limitations. At Brigham & Women's Hospital in Boston, a new blood test is letting researchers look at patients' whole histories of viral infection, using their antibodies as a permanent record.
    Full story
  • Vicon Celebrates Accelerated Growth in Life Sciences with the Addition of New Customers

    Jun 5, 2015, 00:00 AM by Michael Croft
    OXFORD, UNITED KINGDOM - Jun 5, 2015 - Motion capture technology specialist Vicon has announced growing momentum in the life sciences sector with several recent customer wins
    Full story
  • Rho Chairman and Co-Founder Ronald W. Helms Inducted as a Fellow Of the Society for Clinical Trials

    Jun 5, 2015, 00:00 AM by Michael Croft
    CHAPEL HILL, NC - Jun 5, 2015 - For Immediate Release Rho Chairman and Co-Founder Ronald W. Helms Inducted as a FellowOf the Society for Clinical Trials Chapel Hill, NC  ̶  June 4, 2015  ̶  Rho, a contract research organization (CRO) focused on bringing new products to market through a full range of product development services, recently announced that its Chairman and Co-founder Ronald W
    Full story
  • Frontier Pharma: Parkinsons Disease - Identifying and Commercializing First-in-Class Innovation

    Jun 4, 2015, 00:00 AM by Michael Croft
    ALBANY, UNITED STATES - Jun 4, 2015 - Market Research Reports Search Engine (MRRSE) has announced the addition of the ' Frontier Pharma: Parkinsons Disease - Identifying and Commercializing First-in-Class Innovation' report by Market Research Reports Search Engine to its rapidly growing market research report database
    Full story
  • Celgene Bluebird Streamline CAR-T Partnership To Fight Myeloma

    Jun 4, 2015, 00:00 AM by Michael Croft
    Xconomy | The immuno-oncology field is moving fast these days, but the tough-to-treat blood cancer multiple myeloma has not been one of its early targets.
    Full story
  • Business The billion-dollar biotech

    Jun 4, 2015, 00:00 AM by Michael Croft
    Nature News & Comment | Moderna Therapeutics has big ambitions and a bankroll to match. How a fledgling start-up became one of the most highly valued private drug firms ever.
    Full story
  • Genomics England Names Four Finalist Companies to Begin Interpretation

    Jun 3, 2015, 13:00 PM by Michael Croft
    Bio-IT World News Brief | Genomics England today announced four finalist companies and one alternate that will begin working on the interpretation of the genomes of the first 8,000 patients participating in the 100,000 Genomes Project.  Congenica and Omicia will work in rare diseases, Nanthealth in cancer, and Wuxi Nextcode in both rare disease and cancer for this stage of the project. Lockheed Martin in partnership with Cypher Genomics is the alternate.
    Full story
  • Thomson Reuters Honors Top BioPharma Deals

    Jun 3, 2015, 00:00 AM by Michael Croft
    PHILADELPHIA, PA, UNITED STATES - Jun 3, 2015 - The Intellectual Property and Science business of Thomson Reuters, the world’s leading provider of intelligent information for businesses and professionals, recently honored Genentech Partnering and Seragon, and Regeneron and Avalanche with the Allicense 2015 Breakthrough Award for Deals of the Year
    Full story
  • BaseHealth Opens Its Genomic Health Engine to Outside Developers

    Jun 2, 2015, 15:00 PM by Michael Croft
    Bio-IT World | BaseHealth, an Illumina-associated company using genomic data to provide patients with personalized health recommendations, is shifting to a more behind-the-scenes model, releasing an open API to integrate its own analysis engine into third-party apps and health platforms.
    Full story
  • Trinity Pharma Solutions Announces the Next Generation of its Enterprise Cloud Data and Analytics Platform for Life Sciences

    Jun 2, 2015, 00:00 AM by Michael Croft
    WALTHAM, MA - Jun 2, 2015 - Trinity Pharma Solutions, a leader in cloud-based data and guided analytics solutions for the global life sciences industry, today announced the next generation of its cloud-enabled and mobile-ready data analytics platform
    Full story
  • Invitae Launches Direct-to-Consumer Pricing

    Jun 1, 2015, 14:00 PM by Michael Croft
    Bio-IT World | Invitae Corporation today announced a patient pay price for its full menu of genetic tests. For $475 per indication, patients can pay for their own genetic tests if insurance coverage is not available. The price covers all of Invitae’s offerings in cancer, cardiology, neurology, pediatric genetics, hematology and other rare conditions
    Full story
  • May News and Product Briefs

    Jun 1, 2015, 12:25 PM by Michael Croft
    Bio-IT World | News and product briefs from around the industry, including a suite of new proteomics and lipidomics solutions from SCIEX, and new efforts at the Broad Institute to understand the mechanisms of cancer drug resistance.
    Full story
  • Google cloud strategy focuses on analyzing big data

    Jun 1, 2015, 00:00 AM by Michael Croft
    Computerworld | Google may not have caught up to Amazon in the cloud market, but that's OK, according to a Google executive. The company is heading in a slightly different direction with cloud computing that involves helping customers analyze their data.
    Full story
  • Definiens Launches Biomarker Datafication Services

    May 29, 2015, 15:00 PM by Michael Croft
    Bio-IT World News Brief | Definiens today launched a new suite of Biomarker Datafication Services for oncology clinical development programs. The package provides image analysis screening of tissue samples for exploratory screening, pharmacokinetics/pharmacodynamics, and companion diagnostic development.
    Full story
  • PacBio Aims for Haplotyped Whole Genome Assemblies in Partnership with RainDance

    May 29, 2015, 11:50 AM by Michael Croft
    Bio-IT World | Months after 10X Genomics came to market with a platform for reassembling 100-kilobase DNA fragments with an Illumina sequencer, Pacific Biosciences and RainDance Technologies have teamed up on their own barcoded long read solution that they say could outperform 10X on virtually every count.
    Full story